The Motley Fool

PARA BIO FPO (ASX: PAR) Share Price and News

 Chart and Price Data

20mins delayed

.

Price
Bid/Ask /
Volume
Avg Daily Volume
Day Movement
Day High/Low /
52 Week Range -
Year Return (Capital)
As at
Please Wait...

PARA BIO FPO (ASX: PAR) Latest News

Top brokers name 3 ASX shares to sell today

Top brokers have named Commonwealth Bank of Australia (ASX:CBA) and these ASX shares as sells this week. Here's why they are bearish... More »


increasing bar graph created from medical tablets

Why the Paradigm share price is rising today

The Paradigm share price is rising today after the company released promising results in its United States FDA expanded access program. More »


Biotechnology graphics

4 exciting ASX biotech shares surging higher today

The ASX biotech segment has been on fire today. Here we take a closer look at 4 ASX biotech shares that have seen particularly... More »


Doctor with stethoscope in hand and data graph showing upward trend

3 ASX medical shares to hold for the long term

ASX medical shares are among the most defensive shares on the ASX. Here we take a look at 3 healthcare companies to hold for... More »


Piggy Bank Stethoscope

Stock of the day: Paradigm Biopharmaceuticals share price climbs 6% on clinical data

The Paradigm Biopharmaceuticals share price climbed 6% today following promising results from a trial of its osteoarthritis drug. More »


man walking up line graph into clouds, asx shares all time high

Why Afterpay, ELMO, Oil Search, & Paradigm shares are racing higher

Afterpay Ltd (ASX:APT) and ELMO Software Ltd (ASX:ELO) shares are two of four racing higher on Wednesday. Here's why... More »


Biotechnology graphics

3 ASX biotech shares that have soared higher today

The ASX is home to a small but vibrant and growing biotechnology sector. Here we look at 3 ASX biotech shares that have soared... More »


Rocket soaring through the sky

ASX stock of the day: Paradigm Biopharmaceuticals share price rockets 9% after clinical trials see chronic pain in osteoarthritis patients drop by 44%

The Paradigm Biopharmaceuticals Limited (ASX: PAR) share price is up 9.03% today after the healthcare company reported strong results from its clinical studies. More »


shares higher

Why Afterpay, Baby Bunting, Paradigm, & Saracen shares are storming higher

Afterpay Ltd (ASX:APT) and Paradigm Biopharmaceuticals Ltd (ASX:PAR) shares are two of four storming notably higher on Tuesday... More »


biotech shares

Paradigm share price rockets 17% higher on Zilosul update

The Paradigm Biopharmaceuticals Ltd (ASX: PAR) share price is rocketing higher on Tuesday. Here's why its shares are up 17% this morning... More »


Health technology shares

Why this ASX healthcare share has risen over 200% in the past year

The Opthea Ltd (ASX: OPT) share price is up more than 200% in the past year. Here we take a closer look at what... More »


success, high flyer, win, challenge

Why these All Ords shares have doubled in value in 12 months

Megaport Ltd (ASX:MP1) and these ASX shares have doubled in value over the last 12 months. Here's why they are flying high... More »


medical research

Why Paradigm Biopharmaceuticals is one to watch in 2020

Paradigm Biopharmaceuticals Ltd (ASX: PAR) shares have tripled in value over the last 12 months. Here's a closer look at the company and why... More »


Jackpot Money Rain

These 3 ASX healthcare shares could make you rich

Here are 3 ASX healthcare shares looking to carve out their own niches – and in doing so, might even grow into tomorrow’s CSL... More »